Literature DB >> 19606277

Fluorescence lifetime imaging microscopy for the characterization of atherosclerotic plaques.

Jennifer Phipps1, Yinghua Sun, Ramez Saroufeem, Nisa Hatami, Laura Marcu.   

Abstract

Atherosclerotic plaque composition has been associated with plaque instability and rupture. This study investigates the use of fluorescence lifetime imaging microscopy (FLIM) for mapping plaque composition and assessing features of vulnerability. Measurements were conducted in atherosclerotic human aortic samples using an endoscopic FLIM system (spatial resolution of 35 mum; temporal resolution 200 ps) developed in our lab which allows mapping in one measurement the composition within a volume of 4 mm diameter x 250 mum depth. Each pixel in the image represents a corresponding fluorescence lifetime value; images are formed through a flexible 0.6 mm side-viewing imaging bundle which allows for further intravascular applications. Based on previously recorded spectra of human atherosclerotic plaque, fluorescence emission was collected through two filters: f1: 377/50 and f2: 460/60 (center wavelength/bandwidth), which together provides the greatest discrimination between intrinsic fluorophores related to plaque vulnerability. We have imaged nine aortas and lifetime images were retrieved using a Laguerre expansion deconvolution technique and correlated with histopathology. Early results demonstrate discrimination using fluorescence lifetime between early, lipid-rich, and collagen-rich lesions which are consistent with previously reported time-resolved atherosclerotic plaque measurements.

Entities:  

Year:  2009        PMID: 19606277      PMCID: PMC2709872          DOI: 10.1117/12.813087

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  9 in total

1.  Pathology of the vulnerable plaque.

Authors:  Renu Virmani; Allen P Burke; Andrew Farb; Frank D Kolodgie
Journal:  J Am Coll Cardiol       Date:  2006-04-18       Impact factor: 24.094

2.  Fast model-free deconvolution of fluorescence decay for analysis of biological systems.

Authors:  Javier A Jo; Qiyin Fang; Thanassis Papaioannou; Laura Marcu
Journal:  J Biomed Opt       Date:  2004 Jul-Aug       Impact factor: 3.170

3.  Low density lipoprotein undergoes oxidation within lysosomes in cells.

Authors:  Yichuan Wen; David S Leake
Journal:  Circ Res       Date:  2007-04-19       Impact factor: 17.367

4.  Discrimination of human coronary artery atherosclerotic lipid-rich lesions by time-resolved laser-induced fluorescence spectroscopy.

Authors:  L Marcu; M C Fishbein; J M Maarek; W S Grundfest
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-07       Impact factor: 8.311

5.  Biochemical basis for the difference between normal and atherosclerotic arterial fluorescence.

Authors:  L I Laifer; K M O'Brien; M L Stetz; G R Gindi; T J Garrand; L I Deckelbaum
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

6.  In vivo detection of macrophages in a rabbit atherosclerotic model by time-resolved laser-induced fluorescence spectroscopy.

Authors:  Laura Marcu; Qiyin Fang; Javier A Jo; Thanassis Papaioannou; Amir Dorafshar; Todd Reil; Jian-Hua Qiao; J Dennis Baker; Julie A Freischlag; Michael C Fishbein
Journal:  Atherosclerosis       Date:  2005-04-02       Impact factor: 5.162

Review 7.  Imaging of atherosclerotic cardiovascular disease.

Authors:  Javier Sanz; Zahi A Fayad
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

8.  Detection of rupture-prone atherosclerotic plaques by time-resolved laser-induced fluorescence spectroscopy.

Authors:  Laura Marcu; Javier A Jo; Qiyin Fang; Thanassis Papaioannou; Todd Reil; Jian-Hua Qiao; J Dennis Baker; Julie A Freischlag; Michael C Fishbein
Journal:  Atherosclerosis       Date:  2008-09-06       Impact factor: 5.162

9.  Identifying the vulnerable patient with rupture-prone plaque.

Authors:  Howard S Weintraub
Journal:  Am J Cardiol       Date:  2008-06-16       Impact factor: 2.778

  9 in total
  5 in total

1.  Fluorescence lifetime imaging for the characterization of the biochemical composition of atherosclerotic plaques.

Authors:  Jennifer Phipps; Yinghua Sun; Ramez Saroufeem; Nisa Hatami; Michael C Fishbein; Laura Marcu
Journal:  J Biomed Opt       Date:  2011-09       Impact factor: 3.170

2.  Multimodal characterization of compositional, structural and functional features of human atherosclerotic plaques.

Authors:  Yang Sun; Abhijit J Chaudhari; Matthew Lam; Hongtao Xie; Diego R Yankelevich; Jennifer Phipps; Jing Liu; Michael C Fishbein; Jonathan M Cannata; K Kirk Shung; Laura Marcu
Journal:  Biomed Opt Express       Date:  2011-07-19       Impact factor: 3.732

Review 3.  Fluorescence lifetime in cardiovascular diagnostics.

Authors:  Laura Marcu
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

4.  Nonlinear optical microscopy in decoding arterial diseases.

Authors:  Alex C-T Ko; Andrew Ridsdale; Leila B Mostaço-Guidolin; Arkady Major; Albert Stolow; Michael G Sowa
Journal:  Biophys Rev       Date:  2012-05-17

5.  Comprehensive intravascular imaging of atherosclerotic plaque in vivo using optical coherence tomography and fluorescence lifetime imaging.

Authors:  Min Woo Lee; Joon Woo Song; Woo Jae Kang; Hyeong Soo Nam; Tae Shik Kim; Sunwon Kim; Wang-Yuhl Oh; Jin Won Kim; Hongki Yoo
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.